EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integrating APCS Score With Dual Biomarker Testing ( FIT + mSEPT9 ) for Precision Risk Stratification and Predictive Modeling in High‐Risk Populations for Colorectal Cancer

WeiKang Ye, Wei Xu, WenTing Yu, Xiuping Wan, Liu He, Maoning Liu, XinMing Lei iD

Annals of Gastroenterological Surgery · 10.11.2026

DOI: 10.1002/ags3.70301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Gastroenterological Surgery, online erschienen am 10.11.2026. Verfasst von WeiKang Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopancreaticobiliary Surgery The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital Quzhou ZheJiang…. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the diagnostic performance of integrating the Asia‐Pacific Colorectal Screening (APCS) score with dual biomarker testing comprising the fecal immunochemical test (FIT) and blood‐based methylated Septin9 (mSEPT9) for risk stratification and detection of advanced colorectal neoplasia (ACN) in a high‐risk population, using colonoscopy with pathological examination as the reference standard.

Methods

A retrospective analysis included 115 patients who underwent FIT, plasma mSEPT9 testing, and colonoscopy between January 2024 and December 2025. FIT was analyzed quantitatively for ROC analysis, while the 20 μg/g threshold was used for binary operating characteristics. Logistic models included ordinal APCS tier, ln(FIT + 1), and mSEPT9 status. The triple‐model threshold was selected by the Youden index, and 1000 bootstrap resamples were used for internal validation.

Results

Among 115 participants, 45 had ACN, including 20 CRCs and 25 advanced adenomas. Quantitative FIT yielded an AUC of 0.836 (95% CI, 0.762–0.910). Apparent AUCs were 0.873 for APCS + FIT and 0.912 for APCS + FIT + mSEPT9 (ΔAUC = 0.039; p = 0.047). At a cutoff of 0.318, the triple model showed 91.1% sensitivity, 68.6% specificity, 65.1% PPV, and 92.3% NPV. The optimism‐corrected AUC was 0.886 for the triple model and 0.852 for APCS + FIT; corrected ΔAUC was 0.034 (95% CI, −0.007 to 0.078).

Conclusion

The integrated model showed high apparent discrimination and sensitivity for ACN, but the incremental benefit over APCS + FIT was uncertain after internal validation. Prospective external validation is required before clinical implementation.

Schlagwörter

Stichwörter der Autor:innen

colorectal neoplasmsfecal immunochemical testmass screeningrisk assessmenttumor biomarkers

Autor:innen und Institutionen

  • Department of Hepatopancreaticobiliary Surgery The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital Quzhou ZheJiang People's Republic of China.
  • Department of Gastrointestinal Endoscopy Center The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital Quzhou ZheJiang People's Republic of China.
  • Department of Gastroenterology The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital Quzhou ZheJiang People's Republic of China.
  • Department of Gastroenterology Yiwu Central Hospital Jinhua ZheJiang People's Republic of China.

ORCID-Profile: XinMing Lei

Zitieren

APA

Ye, W., Xu, W., Yu, W., Wan, X., He, L., Liu, M., & Lei, X. (2026). Integrating APCS Score With Dual Biomarker Testing ( FIT + mSEPT9 ) for Precision Risk Stratification and Predictive Modeling in High‐Risk Populations for Colorectal Cancer. Annals of Gastroenterological Surgery. https://doi.org/10.1002/ags3.70301

Vancouver

Ye W, Xu W, Yu W, Wan X, He L, Liu M, et al. Integrating APCS Score With Dual Biomarker Testing ( FIT + mSEPT9 ) for Precision Risk Stratification and Predictive Modeling in High‐Risk Populations for Colorectal Cancer. Annals of Gastroenterological Surgery. 2026. doi:10.1002/ags3.70301

BibTeX
@article{Ye2026,
  author = {Ye, WeiKang and Xu, Wei and Yu, WenTing and Wan, Xiuping and He, Liu and Liu, Maoning and Lei, XinMing},
  title = {Integrating APCS Score With Dual Biomarker Testing ( FIT + mSEPT9 ) for Precision Risk Stratification and Predictive Modeling in High‐Risk Populations for Colorectal Cancer},
  journal = {Annals of Gastroenterological Surgery},
  year = {2026},
  doi = {10.1002/ags3.70301}
}
Kostenlos starten →